MAIN
: Oncology
Welcome,
VIN Public
!
Logout
Welcome
VIN
Logout
Change Your Password
WSAVA2013
close
VIN Public
Log out
Welcome
Logout
Change Your Password
CLOSE
Attend the next WSAVA Congress
Search this Resource
View main page
Table of Contents
Browse by Speaker
Browse by Category
Loading...
Alternative/Holistic Medicine
Anesthesia & Pain Management
Animal Welfare
Award Lectures
Behavior
Cardiology
Clinical Immunology
Clinical Pathology
Critical Care
Dentistry
Dermatology
Diagnostic Imaging
Emergency Medicine
Endocrinology
Exotics/Wildlife
Feline
Fracture Surgery
Gastrointestinal Surgery
Hereditary
Joint Surgery
Management
Medicine
NAVC How I Treat…
Neurology
Neurology/Surgery
Nurses
Nutrition
Oncologic Surgery
Oncology
Chemotherapy Drugs
Bladder Matters
Cutting Edge Treatments
Imatinib & Mast Cell Tumors
Molecular-Targeting Therapy
Soft & Hard Tissue Sarcomas
One Health/Zoonotic
Ophthalmology
Pharmacology
Physical Rehabilitation
Reproduction
Thoracic Surgery
Urogenital Surgery
Working Dog
Oncology
Check the box in front of the titles you wish to view, print or save as one document. Choose "View Checked" to view or save the document. Press "Print Checked" to print.
"Metronomics": New Applications for Old Chemotherapy Drugs
Chemotherapy Drugs
Anthony J. Mutsaers, DVM, PhD, DACVIM (Oncology)
Bladder Matters - Treatment Options for Transitional Cell Carcinoma
Bladder Matters
Anthony J. Mutsaers, DVM, PhD, DACVIM (Oncology)
Cutting Edge Treatments (Scalpel Not Required)
Cutting Edge Treatments
Anthony J. Mutsaers, DVM, PhD, DACVIM (Oncology)
Molecular Basis of Imatinib Therapy in Mast Cell Tumors
Imatinib & Mast Cell Tumors
Makoto Bonkobara, DVM, PhD
Molecular-Targeting Therapy With Imatinib in Mast Cell Tumors
Molecular-Targeting Therapy
Makoto Bonkobara, DVM, PhD
Soft and Hard Tissue Sarcomas
Soft & Hard Tissue Sarcomas
Anthony J. Mutsaers, DVM, PhD, DACVIM (Oncology)
MAIN
: Oncology
Menu/search
SAID=27